Serplulimab

Hetronifly

CroatiaMarketed

In other countries

The same active substances on other registers, the same brand first.

Hetronifly 10 MG/ML Concentrado Para Solucion Para PerfusionSpain · 100 mg · concentrado para solución para perfusión · Accord Healthcare S.L.U.Same brand
HetroniflyEuropean Union · Accord Healthcare S.L.U.Same brand
HetroniflyItaly · Concentrato per soluzione per infusione · Accord Healthcare, S.L.U.Same brand
HETRONIFLY 10 mg/ml concentraat voor oplossing voor infusie.Netherlands · Concentraat voor oplossing voor infusie · Accord Healthcare S.L.U.Same brand
OlizuBrazil · Abbott Laboratórios do Brasil LtdaSame form
ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10mlSingapore · 100mg/10ml · injection, solution, concentrate · Abbott Laboratories (Singapore ) Private LimitedSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Serplulimab

Hetronifly

CroatiaMarketed

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Serplulimab
Register: Croatia (HALMED)
Status: Marketed
Status in the register: stavljeno u promet; nema nestašice
Registration: 17645
ATC code: L01FF12
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: na recept; u ljekarni